Correlation Between Petros Pharmaceuticals and Pluri
Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and Pluri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and Pluri into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Petros Pharmaceuticals and Pluri Inc, you can compare the effects of market volatilities on Petros Pharmaceuticals and Pluri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of Pluri. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and Pluri.
Diversification Opportunities for Petros Pharmaceuticals and Pluri
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Petros and Pluri is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and Pluri Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluri Inc and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with Pluri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluri Inc has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and Pluri go up and down completely randomly.
Pair Corralation between Petros Pharmaceuticals and Pluri
Given the investment horizon of 90 days Petros Pharmaceuticals is expected to under-perform the Pluri. In addition to that, Petros Pharmaceuticals is 2.9 times more volatile than Pluri Inc. It trades about -0.09 of its total potential returns per unit of risk. Pluri Inc is currently generating about 0.01 per unit of volatility. If you would invest 551.00 in Pluri Inc on March 5, 2025 and sell it today you would lose (104.00) from holding Pluri Inc or give up 18.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Petros Pharmaceuticals vs. Pluri Inc
Performance |
| Timeline |
| Petros Pharmaceuticals |
| Pluri Inc |
Petros Pharmaceuticals and Pluri Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Petros Pharmaceuticals and Pluri
The main advantage of trading using opposite Petros Pharmaceuticals and Pluri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, Pluri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluri will offset losses from the drop in Pluri's long position.| Petros Pharmaceuticals vs. Sunshine Biopharma | ||
| Petros Pharmaceuticals vs. Sonoma Pharmaceuticals | ||
| Petros Pharmaceuticals vs. Alpha Teknova | ||
| Petros Pharmaceuticals vs. Evoke Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |